Tokyo Tape
Sign in
← CellSeed

Half-year report · HY

7776.TEDINET S100YWQY
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥21m2026-01-01 → 2026-06-30StandaloneNet sales
Revenue¥84m2025-01-01 → 2025-12-31StandaloneNet sales (5-year summary)
Revenue¥37m2025-01-01 → 2025-06-30StandaloneNet sales
Operating income−¥571m2026-01-01 → 2026-06-30StandaloneOperating income
Operating income−¥623m2025-01-01 → 2025-06-30StandaloneOperating income
Ordinary income−¥576m2026-01-01 → 2026-06-30StandaloneOrdinary income
Ordinary income−¥1.1bn2025-01-01 → 2025-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥624m2025-01-01 → 2025-06-30StandaloneOrdinary income
Profit before tax−¥609m2026-01-01 → 2026-06-30StandaloneIncome before income taxes
Profit before tax−¥651m2025-01-01 → 2025-06-30StandaloneIncome before income taxes
Net income−¥611m2026-01-01 → 2026-06-30StandaloneProfit loss
Net income−¥1.1bn2025-01-01 → 2025-12-31StandaloneNet income loss (5-year summary)
Net income−¥651m2025-01-01 → 2025-06-30StandaloneProfit loss
Total assets¥2.1bnat 2026-06-30StandaloneAssets
Total assets¥1.7bnat 2025-12-31StandaloneAssets
Total assets¥1.9bnat 2025-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥311mat 2026-06-30StandaloneLiabilities
Total liabilities¥387mat 2025-12-31StandaloneLiabilities
Net assets / equity¥1.8bnat 2026-06-30StandaloneNet assets
Net assets / equity¥1.3bnat 2025-12-31StandaloneNet assets
Net assets / equity¥1.5bnat 2025-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.8bnat 2026-06-30StandaloneCash and deposits
Cash and deposits¥1.3bnat 2025-12-31StandaloneCash and deposits
Cash & equivalents¥1.8bnat 2026-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2025-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.7bnat 2025-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2024-12-31vStandaloneCash and cash equivalents
Operating cash flow−¥566m2026-01-01 → 2026-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥989m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥473m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥46m2026-01-01 → 2026-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥27m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥717,0002025-01-01 → 2025-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥1.1bn2026-01-01 → 2026-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥200m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-15.932026-01-01 → 2026-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-31.822025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.782025-01-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio84.5%at 2026-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio76.0%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.5%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued39,319,219at 2026-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued35,557,719at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued34,666,419at 2025-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2026-01-01 → 2026-06-30−¥134m
Cell Sheet Regenerative Medicinereportable segmentrevenue2026-01-01 → 2026-06-30¥4m
Cell Sheet Regenerative Medicinereportable segmentrevenue external2026-01-01 → 2026-06-30¥4m
Cell Sheet Regenerative Medicinereportable segmentsegment profit2026-01-01 → 2026-06-30−¥364m
Laboratory Consumable Equipmentreportable segmentrevenue2026-01-01 → 2026-06-30¥16m
Laboratory Consumable Equipmentreportable segmentrevenue external2026-01-01 → 2026-06-30¥16m
Laboratory Consumable Equipmentreportable segmentsegment profit2026-01-01 → 2026-06-30−¥72m
—segment totalrevenue2026-01-01 → 2026-06-30¥21m
—segment totalrevenue external2026-01-01 → 2026-06-30¥21m
—segment totalsegment profit2026-01-01 → 2026-06-30−¥437m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥115m
Cell Sheet Regenerative Medicinereportable segmentrevenue2025-01-01 → 2025-06-30¥2m
Cell Sheet Regenerative Medicinereportable segmentrevenue external2025-01-01 → 2025-06-30¥2m
Cell Sheet Regenerative Medicinereportable segmentsegment profit2025-01-01 → 2025-06-30−¥449m
Laboratory Consumable Equipmentreportable segmentrevenue2025-01-01 → 2025-06-30¥35m
Laboratory Consumable Equipmentreportable segmentrevenue external2025-01-01 → 2025-06-30¥35m
Laboratory Consumable Equipmentreportable segmentsegment profit2025-01-01 → 2025-06-30−¥59m
—segment totalrevenue2025-01-01 → 2025-06-30¥37m
—segment totalrevenue external2025-01-01 → 2025-06-30¥37m
—segment totalsegment profit2025-01-01 → 2025-06-30−¥508m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 441
ItemContextValueUnit
Valuation difference on available for sale securitiesInterimInstant_NonConsolidatedMember2098000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember1607000JPY
Valuation and translation adjustmentsInterimInstant_NonConsolidatedMember2098000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember10748000JPY
Subscription rights to sharesInterimInstant_NonConsolidatedMember12181000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1268381000JPY
Net assetsInterimInstant_NonConsolidatedMember1773979000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember1655840000JPY
Liabilities and net assetsInterimInstant_NonConsolidatedMember2084835000JPY
Net salesPrior1InterimDuration_NonConsolidatedMember36998000JPY
Net salesInterimDuration_NonConsolidatedMember20820000JPY
Cost of salesPrior1InterimDuration_NonConsolidatedMember22653000JPY
Cost of salesInterimDuration_NonConsolidatedMember9377000JPY
Gross profitPrior1InterimDuration_NonConsolidatedMember14344000JPY
Gross profitInterimDuration_NonConsolidatedMember11442000JPY
Research and development expenses sgaPrior1InterimDuration_NonConsolidatedMember451208000JPY
Research and development expenses sgaInterimDuration_NonConsolidatedMember363133000JPY
Other sgaPrior1InterimDuration_NonConsolidatedMember186406000JPY
Other sgaInterimDuration_NonConsolidatedMember219267000JPY
Selling general and administrative expensesPrior1InterimDuration_NonConsolidatedMember637615000JPY
Selling general and administrative expensesInterimDuration_NonConsolidatedMember582400000JPY
Operating incomePrior1InterimDuration_NonConsolidatedMember-623270000JPY
Operating incomeInterimDuration_NonConsolidatedMember-570958000JPY
Interest income noiPrior1InterimDuration_NonConsolidatedMember1100000JPY
Interest income noiInterimDuration_NonConsolidatedMember1500000JPY
Commission fee noiPrior1InterimDuration_NonConsolidatedMember－JPY
Commission fee noiInterimDuration_NonConsolidatedMember259000JPY
Income from fees for business noiPrior1InterimDuration_NonConsolidatedMember－JPY
Income from fees for business noiInterimDuration_NonConsolidatedMember1200000JPY
Other noiPrior1InterimDuration_NonConsolidatedMember18000JPY
Other noiInterimDuration_NonConsolidatedMember29000JPY
Non operating incomePrior1InterimDuration_NonConsolidatedMember1119000JPY
Non operating incomeInterimDuration_NonConsolidatedMember2989000JPY
Interest expenses noePrior1InterimDuration_NonConsolidatedMember978000JPY
Interest expenses noeInterimDuration_NonConsolidatedMember841000JPY
Stock issuance cost prior noePrior1InterimDuration_NonConsolidatedMember－JPY
Stock issuance cost prior noeInterimDuration_NonConsolidatedMember7382000JPY
Foreign exchange losses noePrior1InterimDuration_NonConsolidatedMember839000JPY
Foreign exchange losses noeInterimDuration_NonConsolidatedMember22000JPY
Other noePrior1InterimDuration_NonConsolidatedMember－JPY
Other noeInterimDuration_NonConsolidatedMember1000JPY
Non operating expensesPrior1InterimDuration_NonConsolidatedMember1817000JPY
Non operating expensesInterimDuration_NonConsolidatedMember8246000JPY
Ordinary incomePrior1InterimDuration_NonConsolidatedMember-623969000JPY
Ordinary incomeInterimDuration_NonConsolidatedMember-576215000JPY
Gain on reversal of subscription rights to shares eiPrior1InterimDuration_NonConsolidatedMember－JPY
Gain on reversal of subscription rights to shares eiInterimDuration_NonConsolidatedMember264000JPY
Extraordinary incomePrior1InterimDuration_NonConsolidatedMember－JPY
Extraordinary incomeInterimDuration_NonConsolidatedMember264000JPY
Impairment loss elPrior1InterimDuration_NonConsolidatedMember26717000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2025-12-31pass
balance sheet identitynon_consolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · net assetsnon_consolidated 2026-06-30pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flownon_consolidated 2026-01-01/2026-06-30pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · revenuenon_consolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass
statement vs summary · total assetsnon_consolidated 2026-06-30pass